Safety and Efficacy Study of NOYA Sirolimus-Eluting Stent to Treat Coronary Artery Disease
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2000 participants.
Also called NCT02216058
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 2,000 participants
- Sponsor
- Medfavour (Beijing) Medical Co., Ltd
- Registry
-
NCT02216058
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02216058. Allocation not applicable; no masking; primary purpose treatment. Start 2013-04 (registry gives no type); primary completion 2017-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy Study of NOYA Sirolimus-Eluting Stent to Treat Coronary Artery Disease
- Condition
- Coronary Artery Disease
- Intervention (Device)
- NOYA CoCr Biodegradable Coating Sirolimus-Eluting Stent System
- Lead sponsor
- Medfavour (Beijing) Medical Co., Ltd
Record details
- Record id
cardio:ct-nct02216058- Content hash
d13b44f8b0761069f2e9206079d48107280611f45ca33d78d7b2c8dd9b0b0b1d